PeriplocinPeriplocin
MedChemExpress (MCE)
HY-N1381
13137-64-9
99.92%
4°C, protect from light *In solvent : -80°C, 6 months
-20°C, 1 month (protect from light)
Room temperature in continental US
may vary elsewhere.
Periplocin is a cardiotonic steroid isolated from root-bark Periploca sepium Bunge. Periplocin promotes tumor cell apoptosis and inhibits tumor growth. Periplocin has the potential to facilitate wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase.
Periplocin (5-20 μM
48 hours
L929 cells) treatment shows increased proliferation up to 131% at 20 μM[1]. Periplocin (5-20 μM
30-120 minutes
L929 cells) increases phosphorylation of Src, ERK, PI3K and Akt at active sites in a dosedependent and time-dependent manner. Periplocin (5-20 μM
48 hours) significantly promotes migration of fibroblast cell[1]. Periplocin (5-20 μM
48 hours) increases collagen production in L929 fibroblast[1]. Periplocin induces Na/KATPase mediates the activation of Src/ERK and PI3K/Akt pathways[1].
Periplocin (5-20 mg/kg
intraperitoneal injection
daily
for 14 days
female SCID mice) treatment represses the growth of hepatocellular carcinoma (HCC) in xenograft tumor model in mice[2].
Apoptosis[2] In Vitro Periplocin (5-20 μM
48 hours
L929 cells) treatment shows increased proliferation up to 131% at 20 μM[1]. Periplocin (5-20 μM
30-120 minutes
L929 cells) increases phosphorylation of Src, ERK, PI3K and Akt at active sites in a dosedependent and time-dependent manner. Periplocin (5-20 μM
48 hours) significantly promotes migration of fibroblast cell[1]. Periplocin (5-20 μM
48 hours) increases collagen production in L929 fibroblast[1]. Periplocin induces Na/KATPase mediates the activation of Src/ERK and PI3K/Akt pathways[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Periplocin Related Antibodies Cell Viability Assay[1] Cell Line: L929 cells
| | | |
| | | | | |
[1]. Chen L, et al. Periplocin promotes wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase. Phytomedicine. 2019 Apr
57:72-83. [Content Brief]
[2]. Cheng CF, et al. Antitumor Effect of Periplocin in TRAIL-Resistant Human Hepatocellular Carcinoma Cells through Downregulation of IAPs. Evid Based Complement Alternat Med. 2013
2013:958025. [Content Brief]